Breaking in and busting out: cell-penetrating peptides and the endosomal escape problem.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28841567)

Published in Biomol Concepts on August 25, 2017

Authors

Julia C LeCher1, Scott J Nowak1, Jonathan L McMurry1

Author Affiliations

1: .

Articles cited by this

Cellular uptake of the tat protein from human immunodeficiency virus. Cell (1988) 10.19

The fine structure of the gall bladder epithelium of the mouse. J Biophys Biochem Cytol (1955) 7.88

Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat Med (2004) 6.48

The third helix of the Antennapedia homeodomain translocates through biological membranes. J Biol Chem (1994) 6.04

Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J Biol Chem (2002) 6.01

Clathrin: a unique protein associated with intracellular transfer of membrane by coated vesicles. Proc Natl Acad Sci U S A (1976) 5.52

Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell (1988) 5.26

Tat-mediated delivery of heterologous proteins into cells. Proc Natl Acad Sci U S A (1994) 5.00

Tumor imaging by means of proteolytic activation of cell-penetrating peptides. Proc Natl Acad Sci U S A (2004) 4.95

A comprehensive model for the cellular uptake of cationic cell-penetrating peptides. Traffic (2007) 3.01

Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans. J Biol Chem (2000) 2.98

Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement. Mol Ther (2004) 2.82

Cationic TAT peptide transduction domain enters cells by macropinocytosis. J Control Release (2005) 2.74

Endocytosis and targeting of exogenous HIV-1 Tat protein. EMBO J (1991) 2.62

Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors. J Biol Chem (2005) 2.46

In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer. Integr Biol (Camb) (2009) 2.30

Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1. Proc Natl Acad Sci U S A (2000) 2.23

Antennapedia and HIV transactivator of transcription (TAT) "protein transduction domains" promote endocytosis of high molecular weight cargo upon binding to cell surface glycosaminoglycans. J Biol Chem (2003) 2.23

HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region. AIDS (1997) 2.15

Macropinocytosis: an endocytic pathway for internalising large gulps. Immunol Cell Biol (2011) 2.11

Cell membrane lipid rafts mediate caveolar endocytosis of HIV-1 Tat fusion proteins. J Biol Chem (2003) 2.09

Systemic in vivo distribution of activatable cell penetrating peptides is superior to that of cell penetrating peptides. Integr Biol (Camb) (2009) 1.78

A novel integrin specificity exemplified by binding of the alpha v beta 5 integrin to the basic domain of the HIV Tat protein and vitronectin. J Cell Biol (1993) 1.74

Cell-penetrating peptides: breaking through to the other side. Trends Mol Med (2012) 1.68

Calcium uptake via endocytosis with rapid release from acidifying endosomes. Curr Biol (1998) 1.68

Cell surface adherence and endocytosis of protein transduction domains. Mol Ther (2003) 1.67

Killing HIV-infected cells by transduction with an HIV protease-activated caspase-3 protein. Nat Med (1999) 1.63

Cell-penetrating and cell-targeting peptides in drug delivery. Biochim Biophys Acta (2008) 1.54

Caveolae-mediated internalization of extracellular HIV-1 tat fusion proteins visualized in real time. Mol Ther (2003) 1.52

Cellular internalization and distribution of arginine-rich peptides as a function of extracellular peptide concentration, serum, and plasma membrane associated proteoglycans. Bioconjug Chem (2008) 1.46

HIV-1 Tat enters T cells using coated pits before translocating from acidified endosomes and eliciting biological responses. Mol Biol Cell (2004) 1.38

Translocation and endocytosis for cell-penetrating peptide internalization. J Biol Chem (2009) 1.36

Interaction of HIV-1 Tat protein with heparin. Role of the backbone structure, sulfation, and size. J Biol Chem (1997) 1.32

Clathrin-independent pathways of endocytosis. Cold Spring Harb Perspect Biol (2014) 1.25

Protein delivery into live cells by incubation with an endosomolytic agent. Nat Methods (2014) 1.16

Tumor targeting of MMP-2/9 activatable cell-penetrating imaging probes is caused by tumor-independent activation. J Nucl Med (2011) 1.13

Heparan sulfate proteoglycan as a cell-surface endocytosis receptor. Matrix Biol (2013) 1.13

Translocation of beta-galactosidase mediated by the cell-penetrating peptide pep-1 into lipid vesicles and human HeLa cells is driven by membrane electrostatic potential. Biochemistry (2005) 1.10

Fundamental molecular mechanism for the cellular uptake of guanidinium-rich molecules. J Am Chem Soc (2014) 1.08

The basic domain in HIV-1 Tat protein as a target for polysulfonated heparin-mimicking extracellular Tat antagonists. J Biol Chem (1998) 1.01

In vivo targeting of hydrogen peroxide by activatable cell-penetrating peptides. J Am Chem Soc (2014) 1.00

Effects of the Tat basic domain on human immunodeficiency virus type 1 transactivation, using chemically synthesized Tat protein and Tat peptides. J Virol (1994) 1.00

A syndecan-4/CXCR4 complex expressed on human primary lymphocytes and macrophages and HeLa cell line binds the CXC chemokine stromal cell-derived factor-1 (SDF-1). Glycobiology (2004) 0.99

Cationic PTD/CPP-mediated macromolecular delivery: charging into the cell. Expert Opin Drug Deliv (2015) 0.98

Inhibition of CXCR4-dependent HIV-1 infection by extracellular HIV-1 Tat. Biochem Biophys Res Commun (2000) 0.96

A cancer specific cell-penetrating peptide, BR2, for the efficient delivery of an scFv into cancer cells. PLoS One (2013) 0.94

PTD/CPP peptide-mediated delivery of siRNAs. Curr Pharm Des (2013) 0.93

Xentry, a new class of cell-penetrating peptide uniquely equipped for delivery of drugs. Sci Rep (2013) 0.93

Cell-penetrating peptide exploited syndecans. Biochim Biophys Acta (2010) 0.91

Harnessing the power of cell-penetrating peptides: activatable carriers for targeting systemic delivery of cancer therapeutics and imaging agents. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2012) 0.91

Results of a randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of a botulinum toxin type A topical gel for the treatment of moderate-to-severe lateral canthal lines. J Drugs Dermatol (2012) 0.90

CPPsite 2.0: a repository of experimentally validated cell-penetrating peptides. Nucleic Acids Res (2015) 0.88

Construction of cell penetrating peptide vectors with N-terminal stearylated nuclear localization signal for targeted delivery of DNA into the cell nuclei. J Control Release (2010) 0.88

TAT-mediated delivery of LAD restores pyruvate dehydrogenase complex activity in the mitochondria of patients with LAD deficiency. Mol Ther (2008) 0.86

Identification of a cardiac specific protein transduction domain by in vivo biopanning using a M13 phage peptide display library in mice. PLoS One (2010) 0.85

Peptide-mediated cell penetration and targeted delivery of gold nanoparticles into lysosomes. J Pept Sci (2012) 0.85

Replacement of the C6ORF66 assembly factor (NDUFAF4) restores complex I activity in patient cells. Mol Med (2013) 0.85

Transducible form of p47phox and p67phox compensate for defective NADPH oxidase activity in neutrophils of patients with chronic granulomatous disease. Biochem Biophys Res Commun (2011) 0.82

CXCR4 stimulates macropinocytosis: implications for cellular uptake of arginine-rich cell-penetrating peptides and HIV. Chem Biol (2012) 0.82

Cell-penetrating peptides with intracellular organelle targeting. Expert Opin Drug Deliv (2016) 0.81

Novel cell-penetrating peptide targeting mitochondria. FASEB J (2015) 0.81

Novel cell-penetrating peptide-adaptors effect intracellular delivery and endosomal escape of protein cargos. J Cell Sci (2016) 0.80

Syndecan-4 Is a Receptor for Clathrin-Mediated Endocytosis of Arginine-Rich Cell-Penetrating Peptides. Bioconjug Chem (2016) 0.79

Intracellular delivery of proteins in complexes with oligoarginine-modified liposomes and the effect of oligoarginine length. Bioconjug Chem (2006) 0.78

Syndecan-4 independently regulates multiple small GTPases to promote fibroblast migration during wound healing. Small GTPases (2012) 0.78

Polymer Nanoparticles Modified with Photo- and pH-Dual-Responsive Polypeptides for Enhanced and Targeted Cancer Therapy. Mol Pharm (2016) 0.78

A versatile cell-penetrating peptide-adaptor system for efficient delivery of molecular cargos to subcellular destinations. PLoS One (2017) 0.76

Cell-penetrating and endoplasmic reticulum-locating TAT-IL-24-KDEL fusion protein induces tumor apoptosis. J Cell Physiol (2016) 0.76

Heterologous mitochondrial targeting sequences can deliver functional proteins into mitochondria. Int J Biochem Cell Biol (2016) 0.76

Delivery of Proteins, Peptides or Cell-impermeable Small Molecules into Live Cells by Incubation with the Endosomolytic Reagent dfTAT. J Vis Exp (2015) 0.75